Recruiting at 1 site No phase Multiple Sclerosis, Relapsing-Remitting

Clinical trial for Multiple Sclerosis, Relapsing-Remitting

Official title Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

ClinicalTrials.gov ID: NCT05958381

What this study is testing

What it's testing
The study wants to find out if transcranial direct current stimulation over a memory‑related brain area can improve verbal retrieval and other thinking skills in MS patients.
Who it's for
Adults who have relapsing‑remitting multiple sclerosis.
What's involved
Participants will receive a series of tDCS sessions and will take memory and other cognitive tests, plus have EEG recordings to measure brain activity.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • º Diagnosed with relapsing-remitting multiple sclerosis (RRMS)
  • º Memory retrieval deficit based on neuropsychological testing done in our lab
  • º Must be fluent in speaking and reading English.

You likely can't join if

  • dementia of any type
  • epilepsy or other seizure disorders
  • severe traumatic brain injury
  • brain tumor
  • present drug abuse
  • stroke
See the full eligibility criteria
Who can join
  • º Diagnosed with relapsing-remitting multiple sclerosis (RRMS)
  • º Memory retrieval deficit based on neuropsychological testing done in our lab
  • º Must be fluent in speaking and reading English.
What rules you out
  • dementia of any type
  • epilepsy or other seizure disorders
  • severe traumatic brain injury
  • brain tumor
  • present drug abuse
  • stroke
  • blood vessel abnormalities in the brain
  • Parkinson's disease
  • anti-convulsants
  • L-dopa
  • carbamazepine
  • sulpiride
  • pergolide
  • lorazepam
  • rivastigmine
  • dextromethorphan
  • D-cycloserine
  • flunarizine
  • ropinirole
  • stimulants (dextroamphetamine/amphetamine/modafinil/armodafinil) must be stopped during enrollment

The study team makes the final eligibility decision.

Where it is enrolling

  • Richardson, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Richardson, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.